Sitavig
Product Images NDC 71403-049

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitavig (NDC 71403-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Epi Health, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sitavig 01)

FDA Label Image

Figure A (Sitavig 02)

FDA Label Image

Figure B (Sitavig 03)

FDA Label Image

Figure C (Sitavig 04)

FDA Label Image

Figure D (Sitavig 05)

FDA Label Image

Principal Display Panel (50 mg Tablet Blister Pack Carton)

Principal Display Panel (50 mg Tablet Blister Pack Carton)
This text refers to a medication called Sitavie, which comes in blister packaging with 50mg buccal tablets. The medication is only available with a prescription and the instructions warn against sucking, chewing or swallowing the tablets. The packaging also includes the drug's NDC number, storage instructions, and a warning to keep the medication away from children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.